13-21521286-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_152726.3(MICU2):āc.556A>Gā(p.Thr186Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,610,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_152726.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MICU2 | NM_152726.3 | c.556A>G | p.Thr186Ala | missense_variant | 6/12 | ENST00000382374.9 | NP_689939.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MICU2 | ENST00000382374.9 | c.556A>G | p.Thr186Ala | missense_variant | 6/12 | 1 | NM_152726.3 | ENSP00000371811.4 | ||
MICU2 | ENST00000468222.2 | c.556A>G | p.Thr186Ala | missense_variant | 6/9 | 5 | ENSP00000431792.2 | |||
MICU2 | ENST00000469058.1 | n.648A>G | non_coding_transcript_exon_variant | 7/9 | 5 | |||||
MICU2 | ENST00000476895.5 | n.534A>G | non_coding_transcript_exon_variant | 7/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 247284Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133824
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1458436Hom.: 0 Cov.: 30 AF XY: 0.0000331 AC XY: 24AN XY: 725482
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74376
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at